Monday, Oct 26, 2026
Focus on the big picture

CureVac in Talks With U.S. Over Next-gen Covid Shot: CEO

Bloomberg, 19 Apr 2021
Apr.16 -- CureVac CEO Franz-Werner Haas says the company aims to produce 300 million doses of their mRNA-based vaccine in 2021 and is in discussions ...
Related Articles